{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:57Z","timestamp":1792090017039,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11218-4","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:29:35Z","timestamp":1789165775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Placebo-response inflation in supportive oncology symptom trials: mechanisms, methodological challenges, and design implications"],"prefix":"10.1007","volume":"34","author":[{"given":"Mellar P.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Kiselev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"issue":"6","key":"11218_CR1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cpt.1626","volume":"106","author":"KT Hall","year":"2019","unstructured":"Hall KT, Loscalzo J (2019) Drug-placebo additivity in randomized clinical trials. Clin Pharmacol Ther 106(6):1191\u20131197. https:\/\/doi.org\/10.1002\/cpt.1626","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"11218_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.drudis.2016.11.022","volume":"22","author":"T Kube","year":"2017","unstructured":"Kube T, Rief W (2017) Are placebo and drug-specific effects additive? Questioning basic assumptions of double-blinded randomized clinical trials and presenting novel study designs. Drug Discov Today 22(4):729\u2013735. https:\/\/doi.org\/10.1016\/j.drudis.2016.11.022","journal-title":"Drug Discov Today"},{"key":"11218_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/bs.irn.2018.07.021","volume":"139","author":"MJ Coleshill","year":"2018","unstructured":"Coleshill MJ, Sharpe L, Colloca L, Zachariae R, Colagiuri B (2018) Placebo, and active treatment additivity in placebo analgesia: research to date and future directions. Int Rev Neurobiol 139:407\u2013441. https:\/\/doi.org\/10.1016\/bs.irn.2018.07.021","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"11218_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1176\/appi.ajp.20250034","volume":"183","author":"JT Kantrowitz","year":"2026","unstructured":"Kantrowitz JT, Mayer MR, Choo TH et al (2026) Effect size deflation with increasing sample size in adjunctive trials for negative symptoms in schizophrenia: a meta-analysis and meta-regression across mechanisms of action. Am J Psychiatry 183(3):193\u2013203","journal-title":"Am J Psychiatry"},{"issue":"4","key":"11218_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/npp.2011.306","volume":"37","author":"J Undurraga","year":"2012","unstructured":"Undurraga J, Baldessarini RJ (2012) Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology 37(4):851\u2013864","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"11218_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1017\/S1461145710001641","volume":"14","author":"A Yildiz","year":"2011","unstructured":"Yildiz A, Vieta E, Tohen M, Baldessarini RJ (2011) Factors modifying drug and placebo responses in randomized trials for bipolar mania. Int J Neuropsychopharmacol 14(7):863\u2013875","journal-title":"Int J Neuropsychopharmacol"},{"key":"11218_CR7","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1038\/s41386-019-0440-6","volume":"44","author":"S Leucht","year":"2019","unstructured":"Leucht S, Chaimani A, Mavridis D et al (2019) Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis. Neuropsychopharmacology 44:1955\u20131966","journal-title":"Neuropsychopharmacology"},{"key":"11218_CR8","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/schbul\/sbac061","volume":"48","author":"P Czobor","year":"2022","unstructured":"Czobor P, Kakuszi B, Bitter I (2022) Placebo response in trials of negative symptoms in schizophrenia: a critical reassessment of the evidence. Schizophr Bull 48:1228\u20131240","journal-title":"Schizophr Bull"},{"issue":"3","key":"11218_CR9","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/cncr.24751","volume":"116","author":"M de la Cruz","year":"2010","unstructured":"de la Cruz M, Hui D, Parsons HA, Bruera E (2010) Placebo, and nocebo effects in randomized double-blind clinical trials of agents for the therapy of fatigue in patients with advanced cancer. Cancer 116(3):766\u2013774","journal-title":"Cancer"},{"key":"11218_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2025.05.025","author":"R Singh","year":"2025","unstructured":"Singh R, Manuntag LJ, Jennings K, Bruera E, Yennurajalingam S (2025) Improvement of fatigue due to placebo in blinded and open labeled cancer fatigue treatment trials. J Pain Symptom Manage. https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.05.025","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"11218_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00520-026-10689-9","volume":"34","author":"D Hui","year":"2026","unstructured":"Hui D, Jennings K, Ontai A, Hanneman SK, Bruera E (2026) Predictive biomarkers of placebo response in patients with cancer: an exploratory analysis of the ABCD randomized clinical trial. Support Care Cancer 34(5):345","journal-title":"Support Care Cancer"},{"issue":"1","key":"11218_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jnci\/95.1.19","volume":"95","author":"G Chvetzoff","year":"2003","unstructured":"Chvetzoff G, Tannock IF (2003) Placebo effects in oncology. J Natl Cancer Inst 95(1):19\u201329","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"11218_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jpainsymman.2012.12.005","volume":"46","author":"C Sanderson","year":"2013","unstructured":"Sanderson C, Hardy J, Spruyt O, Currow DC (2013) Placebo and nocebo effects in randomized controlled trials: the implications for research and practice. J Pain Symptom Manage 46(5):722\u2013730","journal-title":"J Pain Symptom Manage"},{"issue":"8","key":"11218_CR14","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/0269216311417036","volume":"26","author":"TM Shelby-James","year":"2012","unstructured":"Shelby-James TM, Hardy J, Agar M et al (2012) Designing and conducting randomized controlled trials in palliative care: a summary of discussions from the 2010 Clinical Research Forum of the Australian Palliative Care Clinical Studies Collaborative. Palliat Med 26(8):1042\u20131047","journal-title":"Palliat Med"},{"key":"11218_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1668","volume":"370","author":"TJ Kaptchuk","year":"2020","unstructured":"Kaptchuk TJ, Hemond CC, Miller FG (2020) Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice. BMJ 370","journal-title":"BMJ"},{"issue":"6","key":"11218_CR16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1056\/NEJMra1907805","volume":"382","author":"L Colloca","year":"2020","unstructured":"Colloca L, Barsky AJ (2020) Placebo and nocebo effects. N Engl J Med 382(6):554\u2013561","journal-title":"N Engl J Med"},{"issue":"11","key":"11218_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.43848","volume":"5","author":"F Gedin","year":"2022","unstructured":"Gedin F, Blome S, Ponten M et al (2022) Placebo response and media attention in randomized clinical trials assessing cannabis-based therapies for pain: a systematic review and meta-analysis. JAMA Netw Open 5(11)","journal-title":"JAMA Netw Open"},{"issue":"5","key":"11218_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jamapsychiatry.2025.0085","volume":"82","author":"NTM Huneke","year":"2025","unstructured":"Huneke NTM, Fusetto Veronesi G, Garner M, Baldwin DS, Cortese S (2025) Expectancy effects, failure of blinding integrity, and placebo response in trials of treatments for psychiatric disorders: a narrative review. JAMA Psychiat 82(5):520\u2013529","journal-title":"JAMA Psychiat"},{"issue":"suppl 1","key":"11218_CR19","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1097\/j.pain.0000000000001929","volume":"162","author":"E Fisher","year":"2021","unstructured":"Fisher E, Moore RA, Fogarty AE et al (2021) Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain 162(suppl 1):S45\u2013S66","journal-title":"Pain"},{"issue":"1","key":"11218_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-2753.2004.00505.x","volume":"11","author":"V Morton","year":"2005","unstructured":"Morton V, Torgerson DJ (2005) Regression to the mean: treatment effect without the intervention. J Eval Clin Pract 11(1):59\u201365","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"11218_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/jamapsychiatry.2021.3204","volume":"79","author":"AJ Scott","year":"2022","unstructured":"Scott AJ, Sharpe L, Quinn V, Colagiuri B (2022) Association of single-blind placebo run-in periods with the placebo response in randomized clinical trials of antidepressants: a systematic review and meta-analysis. JAMA Psychiat 79(1):42\u201349","journal-title":"JAMA Psychiat"},{"key":"11218_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2017.03.001","volume":"87","author":"JS Jensen","year":"2017","unstructured":"Jensen JS, Bielefeldt AO, Hrobjartsson A (2017) Active placebo control groups of pharmacological interventions were rarely used but merited serious considerations: a methodological overview. J Clin Epidemiol 87:34\u201346","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"11218_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41386-020-00911-5","volume":"46","author":"EA Cohen","year":"2021","unstructured":"Cohen EA, Hassman HH, Ereshefsky L et al (2021) Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders. Neuropsychopharmacology 46(4):844\u2013850","journal-title":"Neuropsychopharmacology"},{"key":"11218_CR24","doi-asserted-by":"crossref","unstructured":"Hrobjartsson A, Gotzsche PC (2010) Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. (1):CD003974.","DOI":"10.1002\/14651858.CD003974.pub3"},{"issue":"1","key":"11218_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamainternmed.2017.5308","volume":"178","author":"D Casarett","year":"2018","unstructured":"Casarett D (2018) The Achilles heel of medical cannabis research: inadequate blinding of placebo-controlled trials. JAMA Intern Med 178(1):9\u201310","journal-title":"JAMA Intern Med"},{"issue":"1","key":"11218_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084104","volume":"9","author":"K Lund","year":"2014","unstructured":"Lund K, Vase L, Petersen GL, Jensen TS, Finnerup NB (2014) Randomised controlled trials may underestimate drug effects: balanced placebo trial design. PLoS ONE 9(1). https:\/\/doi.org\/10.1371\/journal.pone.0084104","journal-title":"PLoS ONE"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11218-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:49:11Z","timestamp":1792086551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11218-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11218"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11218-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"5 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Claude and Microsoft Copilot were used for grammar, organization, and manuscript assembly. The authors are responsible for all content.","order":2,"name":"Ethics","label":"Artificial intelligence","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is not a trial but a commentary on trial design.","order":3,"name":"Ethics","label":"Trial","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"962"}}